EUVIMEDEUVIMED entdecken
Multizentrische Studie

Trends in real‐world atropine prescribing for myopia control across evidence eras

Michael L Aaby iD, Brenda L Bohnsack, Michelle R Hribar iD, Rahul Bhola, Noreen A Shaikh iD, Magdalena Stec, Margaret E Overstreet, Jamie E Anderson iD, Arjit Singh, Saron Tedla, Nikita Lalwani iD, Elizabeth S White und 1 weitere

Optometry and Vision Science · 2026-11 · 103 (11)

DOI: 10.1002/ovs2.70112 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Optometry and Vision Science, online erschienen am 02.11.2026. Verfasst von Michael L Aaby und 12 weiteren Autor:innen. Beteiligte Einrichtung: Oregon Health & Science University, Portland, Oregon, USA. Hauptthemen laut MEDLINE: Atropine, Myopia, Practice Patterns, Physicians', Refraction, Ocular. Die Arbeit nennt 25 Literaturangaben. Gefördert von: NEI NIH HHS, Malcolm M. Marquis, MD Endowed Fund for Innovation, Research to Prevent Blindness.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Identify trends in atropine prescribing and concentration adjustments for pediatric myopia control across multiple U.S. academic eye centers.

Methods

A multicenter, retrospective chart review was conducted of children (ages 3–17 years) prescribed low‐concentration atropine for myopia management at three academic medical centers in the United States: the Casey Eye Institute, Oregon Health & Science University, the Ann & Robert H. Lurie Children's Hospital of Chicago, and the Rady Children's Hospital Orange County. Descriptive statistics were used to characterize the data and summarize prescribing patterns, concentration changes, and follow‐up rates by enrollment period and initial atropine concentration.

Results

A total of 435 patients were identified across all study sites. In the Early Low‐Dose Atropine Era, 0.01% atropine was the only starting concentration prescribed. Prescribing subsequently shifted toward higher concentrations. Prescribing of 0.05% atropine increased substantially, accounting for 45.7% of baseline prescriptions. Across subsequent evidence eras, changes in concentration increased in frequency, with greater concentration escalation over time, and these increases were most frequent during the Post‐LAMP Era (24.4%).

Conclusions

A clear shift in atropine prescribing patterns for pediatric myopia management was identified over the course of the study period. During the Early Low‐Dose Atropine Era, clinicians exclusively prescribed the lowest concentration of atropine (0.01%), and only a small proportion of patients were escalated to a higher concentration at 12 months. In the Post‐LAMP Era, there was a broader distribution of baseline dosing, with increased use of 0.02%/0.025% and 0.05% atropine and a higher proportion of patients having concentration increases. During the Contemporary Evidence Era, 0.05% became the predominant starting concentration. The shifts in prescribing patterns highlight the dynamic and responsive nature of clinical decision‐making and underscore a growing trend toward comfortability with personalized myopia management in pediatric eye care, suggesting evolving individualized titration strategies and experimental dosage management methods.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AtropineMyopiaPractice Patterns, Physicians'Refraction, OcularDrug PrescriptionsHumansChildRetrospective StudiesAdolescentChild, PreschoolFemaleMaleMydriaticsOphthalmic SolutionsFollow-Up StudiesDose-Response Relationship, Drug

Substanzen

AtropineMydriaticsOphthalmic Solutions

Autor:innen und Institutionen

  • Oregon Health & Science University, Portland, Oregon, USA.
  • Ann and Robert H. Lurie Children's Hospital of Chicago Foundation, Chicago, Illinois, USA.
  • Casey Eye Institute, Oregon Health & Science University, Portland, Oregon, USA.
  • University of Illinois Chicago College of Medicine, Chicago, Illinois, USA.
  • Rady Children's Hospital Orange County, Orange, California, USA.

ORCID-Profile: Michael L Aaby, Michelle R Hribar, Noreen A Shaikh, Jamie E Anderson, Nikita Lalwani, Allison I Summers

Förderung

  • NEI NIH HHS
  • Malcolm M. Marquis, MD Endowed Fund for Innovation
  • Research to Prevent Blindness
  • National Eye Institute

Zitieren

APA

Aaby, M. L., Bohnsack, B. L., Hribar, M. R., Bhola, R., Shaikh, N. A., Stec, M., Overstreet, M. E., Anderson, J. E., Singh, A., Tedla, S., Lalwani, N., White, E. S., & Summers, A. I. (2026). Trends in real‐world atropine prescribing for myopia control across evidence eras. Optometry and Vision Science, 103(11). https://doi.org/10.1002/ovs2.70112

Vancouver

Aaby ML, Bohnsack BL, Hribar MR, Bhola R, Shaikh NA, Stec M, et al. Trends in real‐world atropine prescribing for myopia control across evidence eras. Optometry and Vision Science. 2026;103(11). doi:10.1002/ovs2.70112

BibTeX
@article{Aaby2026,
  author = {Aaby, Michael L and Bohnsack, Brenda L and Hribar, Michelle R and Bhola, Rahul and Shaikh, Noreen A and Stec, Magdalena and Overstreet, Margaret E and Anderson, Jamie E and Singh, Arjit and Tedla, Saron and Lalwani, Nikita and White, Elizabeth S and Summers, Allison I},
  title = {Trends in real‐world atropine prescribing for myopia control across evidence eras},
  journal = {Optometry and Vision Science},
  year = {2026},
  volume = {103},
  number = {11},
  doi = {10.1002/ovs2.70112}
}
Kostenlos starten →